Clinical trial
TAP (Transverse Abdominis Plane) Block With Exparel (Liposomal Bupivicaine) vs. Bupivicaine Post-op Pain Management
NCT04781075 is registered in ClinicalTrials.gov with Ochsner Health System as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- TAP (Transverse Abdominis Plane) Block With Exparel (Liposomal Bupivicaine) vs. Bupivicaine Post-op Pain Management
- Lead sponsor
- Ochsner Health System
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- December 1, 2017
- Completion date
- July 31, 2021
- Enrollment
- 76 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pain, postoperative